166 related articles for article (PubMed ID: 35661943)
1. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.
Humar B; Blair V; Charlton A; More H; Martin I; Guilford P
Cancer Res; 2009 Mar; 69(5):2050-6. PubMed ID: 19223545
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
[TBL] [Abstract][Full Text] [Related]
5. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
[TBL] [Abstract][Full Text] [Related]
7. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1.
Yamada M; Fukagawa T; Nakajima T; Asada K; Sekine S; Yamashita S; Okochi-Takada E; Taniguchi H; Kushima R; Oda I; Saito Y; Ushijima T; Katai H
Gastric Cancer; 2014 Oct; 17(4):750-6. PubMed ID: 24037103
[TBL] [Abstract][Full Text] [Related]
8. CDH1 gene mutation in early-onset, colorectal signet-ring cell carcinoma.
Aitchison A; Hakkaart C; Whitehead M; Khan S; Siddique S; Ahmed R; Frizelle FA; Keenan JI
Pathol Res Pract; 2020 May; 216(5):152912. PubMed ID: 32147272
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
[TBL] [Abstract][Full Text] [Related]
11. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
13. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
Nikaido M; Kakiuchi N; Miyamoto S; Hirano T; Takeuchi Y; Funakoshi T; Yokoyama A; Ogasawara T; Yamamoto Y; Yamada A; Setoyama T; Shimizu T; Kato Y; Uose S; Sakurai T; Minamiguchi S; Obama K; Sakai Y; Muto M; Chiba T; Ogawa S; Seno H
Gastric Cancer; 2021 Sep; 24(5):1102-1114. PubMed ID: 33961152
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
17. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature.
Hamilton LE; Jones K; Church N; Medlicott S
BMC Gastroenterol; 2013 Jul; 13():114. PubMed ID: 23849133
[TBL] [Abstract][Full Text] [Related]
18. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.
Caggiari L; Miolo G; Canzonieri V; De Zorzi M; Alessandrini L; Corona G; Cannizzaro R; Santeufemia DA; Cossu A; Buonadonna A; De Re V
Cancer Biol Ther; 2018 Apr; 19(4):254-259. PubMed ID: 29131691
[TBL] [Abstract][Full Text] [Related]
19. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
Humar B; Guilford P
Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
[TBL] [Abstract][Full Text] [Related]
20. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P; Humar B; Blair V
Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
